MXPA02004627A - Vacunas contra el micoplasma bovis y sus metodos de uso. - Google Patents

Vacunas contra el micoplasma bovis y sus metodos de uso.

Info

Publication number
MXPA02004627A
MXPA02004627A MXPA02004627A MXPA02004627A MXPA02004627A MX PA02004627 A MXPA02004627 A MX PA02004627A MX PA02004627 A MXPA02004627 A MX PA02004627A MX PA02004627 A MXPA02004627 A MX PA02004627A MX PA02004627 A MXPA02004627 A MX PA02004627A
Authority
MX
Mexico
Prior art keywords
bovis
vaccines
infections
novel
mycoplasma bovis
Prior art date
Application number
MXPA02004627A
Other languages
English (en)
Spanish (es)
Inventor
D Leonard Joan
Original Assignee
Biomune
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomune filed Critical Biomune
Publication of MXPA02004627A publication Critical patent/MXPA02004627A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MXPA02004627A 1999-11-08 2000-11-08 Vacunas contra el micoplasma bovis y sus metodos de uso. MXPA02004627A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16428699P 1999-11-08 1999-11-08
PCT/US2000/042000 WO2001034189A2 (en) 1999-11-08 2000-11-08 Vaccines for mycoplasma bovis and methods of use

Publications (1)

Publication Number Publication Date
MXPA02004627A true MXPA02004627A (es) 2004-02-18

Family

ID=22593810

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02004627A MXPA02004627A (es) 1999-11-08 2000-11-08 Vacunas contra el micoplasma bovis y sus metodos de uso.

Country Status (10)

Country Link
US (7) US7943153B1 (https=)
EP (1) EP1229929A2 (https=)
JP (1) JP2003513935A (https=)
AU (1) AU782508B2 (https=)
BR (1) BR0015398A (https=)
CA (1) CA2390613A1 (https=)
IL (1) IL149471A0 (https=)
MX (1) MXPA02004627A (https=)
WO (1) WO2001034189A2 (https=)
ZA (1) ZA200203622B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0015398A (pt) * 1999-11-08 2002-06-25 Biomune Vacinas para mycoplasma bovis e processos de uso
GB0110851D0 (en) * 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
CA2457514A1 (en) * 2001-08-28 2003-03-06 Pfizer Products Inc. Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
EP2121721A4 (en) * 2006-09-07 2010-10-06 Boehringer Ingelheim Vetmed GENOTYPING ON PCR BASE
CL2008003202A1 (es) 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
EP2217271B1 (en) * 2007-11-06 2016-05-04 Zoetis Services LLC Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
CA2729080C (en) * 2008-07-03 2018-09-11 Ricardo Rosenbusch Cattle vaccines
AU2009309041B2 (en) * 2008-10-31 2016-02-04 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
US9539209B2 (en) 2009-06-04 2017-01-10 National Institute Of Infectious Diseases Vaccine for mycoplasma infection
CN102648003B (zh) 2009-10-09 2016-01-13 儿童医疗中心有限公司 选择性裂解的全细胞疫苗
WO2012041635A1 (en) * 2010-09-29 2012-04-05 Universite De Liege Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis
US9052315B2 (en) 2012-05-09 2015-06-09 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
US10359614B2 (en) 2012-07-03 2019-07-23 Advanced Animal Diagnostics, Inc. Diagnostic apparatus
HUE059179T2 (hu) 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
US9797893B2 (en) 2013-05-09 2017-10-24 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
EP4137152A1 (en) 2015-08-14 2023-02-22 Zoetis Services LLC Mycoplasma bovis compositions
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN113040094B (zh) * 2021-03-18 2022-06-21 中国农业大学 一种牛支原体性小鼠乳腺炎模型的构建方法及其应用
CN116751723A (zh) * 2023-07-24 2023-09-15 吉林农业大学 一种牛支原体菌株及其灭活疫苗和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1188985A (en) 1980-07-01 1985-06-18 National Research Development Corporation Production of viral antigens
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US4517394A (en) * 1983-07-05 1985-05-14 W. R. Grace & Co. Preparation of nitro compounds by vapor phase nitration of carboxylic acids
US4981684A (en) 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
US5178860A (en) 1989-09-01 1993-01-12 Coopers Animal Health Limited Adjuvant complexes and vaccine made therefrom
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2057946A1 (en) * 1990-12-20 1992-06-21 Michael M. Thackeray Electrochemical cell
US5316875A (en) * 1991-07-19 1994-05-31 Matsushita Electric Industrial Co., Ltd. Secondary battery with nonaqueous electrolyte and method of manufacturing same
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5585098A (en) 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
CA2183684C (en) * 1994-02-18 2008-07-15 Richard D. Hansen Inoculation of animals with dried, pelleted biological materials
JP3702353B2 (ja) * 1996-05-24 2005-10-05 日本電池株式会社 リチウム電池用正極活物質の製造方法およびリチウム電池
BR0015398A (pt) * 1999-11-08 2002-06-25 Biomune Vacinas para mycoplasma bovis e processos de uso
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6680143B2 (en) * 2000-06-22 2004-01-20 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
US6677082B2 (en) * 2000-06-22 2004-01-13 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
JP3500424B2 (ja) * 2000-08-31 2004-02-23 独立行政法人産業技術総合研究所 単相リチウムフェライト系複合酸化物
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
BR0015398A (pt) 2002-06-25
ZA200203622B (en) 2003-07-30
US7416734B2 (en) 2008-08-26
AU2622501A (en) 2001-06-06
WO2001034189A2 (en) 2001-05-17
EP1229929A2 (en) 2002-08-14
US20070077260A1 (en) 2007-04-05
JP2003513935A (ja) 2003-04-15
US7943153B1 (en) 2011-05-17
US20080226671A1 (en) 2008-09-18
CA2390613A1 (en) 2001-05-17
AU782508B2 (en) 2005-08-04
WO2001034189A3 (en) 2001-12-27
US20050053627A1 (en) 2005-03-10
US7429389B2 (en) 2008-09-30
IL149471A0 (en) 2002-11-10
US20050118200A1 (en) 2005-06-02
US20090220550A1 (en) 2009-09-03
US20090263427A1 (en) 2009-10-22
US20080069842A9 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
MXPA02004627A (es) Vacunas contra el micoplasma bovis y sus metodos de uso.
US11103569B2 (en) Vaccine for protection against Streptococcus suis
Koprowski et al. Propagation of hog cholera virus in rabbits
EP1854886A3 (en) Cold-adapted equine influenza viruses
US11696944B2 (en) Vaccine for protection against Streptococcus suis
MXPA03011815A (es) Vacuna de micoplasma bovis y metodos para reducir la neumonia en animales.
JP2003513935A5 (https=)
WO2001060849A3 (en) Cold-adapted equine influenza viruses
EP3661546B1 (en) A vaccine for protection against streptococcus suis
WO2001074386A3 (en) Cold-adapted equine influenza viruses
JP5847713B2 (ja) 豚胸膜肺炎に対するワクチン及び当該ワクチンの取得方法
WO1999053950A3 (en) Live vaccines and methods of treatment therewith
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
JP2021506777A (ja) レンサ球菌感染防御のためのワクチン
EP1858550B1 (en) Vaccine formulation
JP2017525726A5 (https=)
KR100766775B1 (ko) 장출혈성대장균(ｅｈｅｃ) 감염증 예방용 톡소이드 백신
IL122829A (en) Isolated strains of staphylococcus aureus and vaccines manufactured therefrom
Martin Respiratory Diseases in Cattle: A Seminar in the EEC Programme of Coordination of Research on Beef Production Held at Edinburgh, November 8–10, 1977
O’Connell et al. The development and testing of a vaccine for the prevention of infectious bovine keratoconjuctivitis
Dowling et al. Cold-adapted equine influenza viruses
Martin Pneumococcal disease
WO2010094699A1 (en) Attenuated salmonella enteritidis strain

Legal Events

Date Code Title Description
FA Abandonment or withdrawal